secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclaris Therapeutics, Inc. (ACRS)
CIK:        0001557746
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001558370-25-000148
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aclaris Therapeutics updates corporate presentation; no material new data disclosed
--------------------------------------------------------------------------------

- Company posted an updated investor presentation on January 13, 2025.
- Presentation content not fully available in this filing for review.
- Routine update; no earnings, pipeline, or financial guidance changes announced.
- Presentation available on Aclaris website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557746/000155837025000148/0001558370-25-000148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557746/000155837025000148/acrs-20250113x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-000148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer